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Abstract Wound infections with multi-drug resistant
bacteria increase morbidity and mortality and have consid-
erable socioeconomic impact. They can lead to impaired
wound healing, resulting in rising treatment costs. The aim
of this study was to investigate an ex vivo human wound
infection model. Human full-thickness skin from the oper-
ating room (OR) was placed into the Bo-Drum® and culti-
vated for 7 days in an air–liquid interphase. On day 8, the
skin was inoculated with either (1) Pseudomonas aerugin-
osa, (2) Staphylococcus aureus (105 CFU, n = 3) or (3) car-
rier control. 1, 3 and 7 days after inoculation colony
forming units in the tissue/media were determined and
cytokine expression was quantiWed. A reliable and repro-
ducible wound infection could be established for 7 days. At
this timepoint, 1.8 £ 108 CFU/g tissue of P. aeruginosa
and 2 £ 107 CFU/g tissue of S. aureus were detected.
Immunohistochemical analysis demonstrated bacterial
infection and epidermolysis in infected skin. RT-PCR anal-
ysis exhibited a signiWcant induction of proinXammatory
cytokines after infection. The BO-drum® is a robust, easy-
to-use, sterilizable and reusable ex vivo full-skin culture
system. For investigation of wound infection, treatment and
healing, the BO-drum® presents a convenient model and
may help to standardize wound research.
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Introduction
The increasing incidence of wound infections with multi-
drug-resistant microbes, such as Staphylococci, Entero-
cocci, and Pseudomonas on intensive care units leads to
further increasing morbidity and mortality among these
patients and is of considerable socioeconomic impact
[30, 31].
Further research into the cellular and molecular func-
tions of the skin may lead to improvements in our under-
standing and management of wounds, but transitional
research from the laboratory to the clinic is not always
straightforward. DiVerent therapies that aVect wound repair
have been proposed over the last few decades. To gain
deeper insights into the biology and pathophysiology of
wound infection, as well as to develop new interventional
therapies, it is paramount to employ convenient, easy-to-
use, and robust experimental models that are versatile and
allow translatability. Studies investigating skin disorders in
humans are limited owing to ethical concerns, leading to
dependence on in vitro and experimental animal models to
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investigate novel therapies and biologic and pathophysio-
logic pathways [3]. Many models have been developed [7],
but in vitro and in vivo models may show poor consistency
with clinical situations [27].
In most cases, the wound-models being investigated are
artiWcial since they are inXicted in healthy animals. How-
ever, most animals exhibit cell biology, histology, immu-
nology, and biochemistry distinct from humans, with
diVerent healing processes, unique complications, and non-
equivalent tissue structures (e.g., the contraction of the sub-
cutaneous muscle panniculus carnosus, which is absent in
humans, and not by reepithelialization). In addition, animal
behavior, therapeutic needs, and skin healing responses
(e.g., inXammation, healing mechanisms, and kinetics) also
diVer from those of humans. The use of animal models to
study wound healing under various stimuli and applied
therapeutic methods is often an attempt to most expediently
duplicate conditions closest to the human patient. Interspe-
cies diVerences in anatomy and physiology, diVerences in
cause and course between natural human disease and artiW-
cially induced nonhuman pathology, and stress experienced
by animals in laboratories invariably alter research results.
Few in vitro or nonmammalian surrogate experiments accu-
rately or adequately duplicate, or recapitulate, the full phys-
iology of the human model for wound healing purposes
[27]. Many research eVorts seek new innovative approaches
to in vitro modeling of in vivo complexity without clear
progress or improved relevance.
In vitro human models help to investigate skin physiol-
ogy and wound healing in a more equivalent fashion. The
major advantage of in vitro models is the opportunity to
analyze environmental changes, substrate and dose–
response interactions, and cutaneous immune responses in a
standard fashion [7, 13].
Wound closure is usually simulated in vitro by simply
creating defects in cell monolayers, and the repopulation of
the defect by adjacent cells through the combined action of
migration and proliferation is then monitored [1]. However,
these models do not reXect the complex process of wound
infection and healing because cell cultures of primary cells
or cell lines neither have a three-dimensional structure nor
show any immune response and systemic interaction. These
systems lack the multidimensional aspects to evaluate
wound healing. As three-dimensional systems are more
representative of normal wound physiology than two-
dimensional systems [9], several approaches to employ
three-dimensional cell cultures have been reported, includ-
ing prefabricated co-culture systems, three-dimensional
gels with incorporated Wbroblasts, and keratinocytes cul-
tured on the apical side of the gel [12, 25]. However, cells
cultured in three-dimensional matrices typically composed
of type I collagen or Wbrin signiWcantly alter their pheno-
type [6]. Extensive phenotypic changes of contractile Wbro-
blasts cultured in three-dimensional matrices are observed
owing to altered mechanical tensions within the systems.
Moreover, newer three-dimensional models utilizing artiW-
cially constructed skin equivalents, which are considered
by many experts to be phenotypically and histologically
similar to that of the in vivo human epidermis [2, 4, 22], are
labor and cost intensive or require expert skills to employ
these systems.
In contrast to skin equivalents, all cellular elements and
their interactions are included in human full-skin culture
explants. Therefore, this approach oVers improved transla-
tion between the investigative laboratory and the clinical
setting. Skin infection and wound healing studies in skin
explants have been performed previously [16, 27], and in
most cases, epithelialization was analyzed [26]. In addition,
the change in tensile strength can be monitored in the
experimental setting [8]. Standardized burn wounds may
also be inXicted in skin explants and assessed for epithelial-
ization by histomorphometry [5]. As a result, this model
provides the opportunity to carry out morphologic studies
of the connective tissue in wound infection and wound
healing [10].
As it is possible to generate wounds and wound infec-
tions in skin explants, it is also possible to pursue their
potential treatment under in vitro conditions. To discrimi-
nate between topical, intradermal, or subdermal treatment,
the used model should have discrete superior and inferior
compartments, which are strictly separated by the cultured
tissue. Therefore, skin explants should be cultured at the
air–liquid interface, which induces physiologic maturation
of keratinocytes to corniWed cells and ensures the preserva-
tion of skin barrier function [19, 21].
The aim of this study was to develop an eVective surro-
gate chamber model for the ex vivo investigation of the
human skin infection and to conWrm this model’s feasibility
for investigation of human skin biology and pathophysiol-
ogy and novel therapeutic approaches, dermal wounding
and infection.
Results
Infection of human full thickness skin 
with P. aeruginosa and S. aureus
To conWrm the feasibility of the Bo-Drum® for studies of
wound infection and skin physiology the establishment of
a wound infection was monitored (Fig. 1). Three days after
infection with S. aureus and P. aeruginosa, tissue samples
were harvested and subjected to bacterial count analysis.
S. aureus infected skin possessed a concentration of
2 £ 107 colony forming units (CFU)/g tissue (P = 0.09).
This group of non-invasive bacteria showed only aArch Dermatol Res (2010) 302:357–365 359
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marginal contamination of the medium in a single cham-
ber (4.79 £ 103 CFU/ml medium). In P. aeruginosa
infected skin samples, a concentration of 1.84 £ 108 CFU/
g tissue (P = 0.28) was determined. Interestingly, this
group of invasive bacteria possessed a high concentration
of bacteria in the medium (2.6 £ 108 CFU/ml medium;
P = 0.003). No bacterial colonialization was observed in
carrier controls.
Time course of bacterial counts after infection 
with S. aureus
For investigation of bacterial colonialization in the Bo-
Drum®, a time course of bacterial infection has been
recorded (Fig. 2). Therefore, the skin was infected with S.
aureus and incubated for at least 7 days. A signiWcant
infection of the skin was seen on day 1 (6.7 £ 107 CFU,
P = 0.04), increasing up to day 7 (1.78 £ 109 CFU;
P = 0.018) after inoculation with S. aureus, whereas non-
infected skin samples did not show any bacterial presence.
A signiWcant augmentation of infection was detected on
day 3 compared to day 1 (P = 0.028) and on day 7 com-
pared to day 1 (P = 0.047).
InXammatory response after infection 
with S. aureus and P. aeruginosa
For investigation of ex vivo skin inXammatory response
after bacterial challenge, cytokine proWling has been per-
formed 3 days after bacterial infection. There was a signiW-
cant induction of type-I-interferons up to 18-fold (IFN-;
P. aeruginosa group; P = 0.0003) after infection with both
S. aureus and P. aeruginosa (Fig. 3). InXammatory cyto-
kines, such as IL-1 and IL-6 showed only a low induction
(IL-1: 3.3-fold, P = 0.15; IL-6: 3.26-fold, P = 0.17) in S.
aureus infected skin. Interestingly, the P. aeruginosa
treated group did not show any induction of these cytokines
(IL-1: 0.5-fold, P = 0.29; IL-6: 0.97-fold, P = 0.97). In
contrast, Il-8 and TNF- exhibited a signiWcant induction
(P. aeruginosa, IL-8: 2.6-fold, P =0 . 1 6 ;  T N F - : 24-fold
P =0 . 0 0 1 ) .
Time course of cytokine expression after infection 
with S. aureus
After analysis of S. aureus and P. aeruginosa induced
inXammatory response, it was interesting to see a time
dependance in cytokine induction. Therefore, a time
course of cytokine expression after inoculation of the
skin was determined via qRT-PCR. There was a signiW-
cant induction of IL-1, increasing up to 48-fold
(P =7£ 10¡5) compared to non-infected skin samples
on day 7 (Fig. 4).
Moreover, a signiWcant induction of IL-6, IL-8 and TNF-
 has been recorded peaking on day 3 [19.3-fold, P =0 . 0 3
Fig. 1 Bacterial infections. Skin specimens were pre-cultured in
Bo-Drums® for 3 days and a dermal wound was created. 3 days after
inoculation with 105 CFU P. aeruginosa or S. aureus, tissue samples
were harvested and homogenized. Both, medium and homoginates,
were plated on isolation agar to determine CFU counts. Values are dis-
played as mean § SEM
Fig. 2 Time course analysis of bacterial infection. Skin explants were
pre-cultured in Bo-Drums® for 3 days. A dermal wound was created
and inoculated with 105 CFU S. aureus. After 1, 3 and 7 days, tissue
samples were harvested and homogenized. Homoginates were plated
on isolation agar to determine CFU counts. Values are displayed as
mean § SEM360 Arch Dermatol Res (2010) 302:357–365
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(IL-1); 21.5-fold, P = 0.01 (IL-6); 29.5-fold, P = 0.07 (IL-8);
6.2-fold, P = 0.002 (TNF-)]. Besides cytokine expression,
type-I-interferons (IFN-/) were also induced after bacte-
rial challenge; peaking on day 3 with a 22.4-fold (IFN-;
P = 0.05) and 7.9-fold (IFN-; P = 0.008) induction.
Immunohistochemical stainings
To visualize and localize the infection on the skin
sections, a haematoxylin/eosin (H&E) staining has been
performed 7 days after S. aureus infection (Fig. 5). Inocu-
lated tissue presents with epidermolysis and bacterial
infection in comparison to a regularly structured epider-
mis in the control. An immunohistochemical staining of
infected skin with anti-S. aureus antibody (green) and
DAPI counterstaining (nuclei; blue) depicts bacterial
infection underneath the epidermal layer and underlying
dermis. In comparison to non-infected control (right) only
few viable cells (blue) are detected at the site of infection,
whereas in the control a regular cell distribution can be
observed.
Fig. 3 ProinXammatory response after bacterial challenge. Tissue
samples were harvested 3 days after infection with S. aureus and P.
aeruginosa and snap frozen until further use. After homogenization,
RNA isolation and cDNA synthesis the expression proWles of selected
cytokines were determined using real-time qRT-PCR. Both groups
were normalized to the non-infected control group. Values are dis-
played as mean § SEM (*P <0 . 0 5 ;  * * P <0 . 0 0 5 )
Fig. 4 Time course analysis of 
skin inXammatory response. 
Tissue samples were harvested 
1–7 days after infection and snap 
frozen until further use. After 
homogenization, RNA isolation 
and cDNA synthesis the expres-
sion proWles of selected cyto-
kines were determined using 
real-time qRT-PCR. Both 
groups were normalized to the 
non-infected control group. 
Values are displayed as 
mean § SEM (*P <0 . 0 5 )Arch Dermatol Res (2010) 302:357–365 361
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Discussion
The organ culture may be the only technique to investigate
the complexity of skin tissue physiology ex vivo and may
therefore bridge the gap between the investigative labora-
tory and the clinical settings.
In general, there is a lack of the ability to recruit inXam-
matory cells in organ skin culture models, but in 1998, Moll
et al. [17] foresaw that the organ skin culture model could
investigate wound healing processes because complex bio-
logic aspects could be observed without any systemic inXu-
ence. Reliable and robust models are needed to bear the
potential of an entire physiologic epithelial environment. In
many prior skin organ culture models, explants were sliced
into small pieces to prevent excessive dermal contraction
and cultured without any tension [14,  17,  29]. This
approach minimized potential opportunities and made
interventional studies impossible because the pieces under
investigation were too small to allow compartmentaliza-
tion.
Several models using reconstituted skin equivalents
were described in previous publications [2,  4,  22]. The
major disadvantages of the application of artiWcially recon-
structed skin are the enormous costs in the construction of
such skin equivalents. Moreover, an application of native
human skin for investigative experiments may be closer to
any individual settings than artiWcially constituted skin
equivalents. This study has established a human ex vivo
full-skin infection model that allows work with the human
skin under deWned in vitro conditions. A stainless steel
chamber was used to apply tension to the cultured full skin
to prevent dermal contraction due to the retraction forces of
the elastic Wbers and physiologically support skin tissue at
an air–liquid interface.
Steinstraesser et al. demonstrated the feasibility of long-
time full-skin cultivation. Using this model, an intact epi-
dermal structure with proliferating cells was depicted after
a cultivation for approximately 4 weeks [28].
In this study, deWned wounds were inXicted into the cul-
tured skin explants. Skin wounds have been infected with
two diVerent bacterial strains (P. aeruginosa and S.
aureus). Since wound infections are deWned as a bacterial
load of 105 CFU/g tissue [23], this study demonstrates the
feasibility for investigation of dermal infections in the Bo-
Drum®. Due to the recess of the inner central opening of the
Bo-Drum® a diVusion of non-invasive bacteria into the
nutrient could be prevented.
However, this could not prevent a contamination of the
medium with P. aeruginosa. This can be explained by the
invasive behaviour of this bacterial strain.
We further investigated the inXammatory response after
bacterial challenge to determine the immunologic function-
Fig. 5 Histological analysis. 
H&E staining of infected skin 
(a) and non-infected control (b) 
at day 7 after S. aureus infection. 
Inoculated tissue presents with 
epidermolysis and bacterial 
infection in comparison to a 
regularly structured epidermis in 
the control. Lower panel immu-
nohistochemical staining of 
infected (c) and non-infected (d) 
skin with anti-S. aureus antibody 
(green) and DAPI counterstain-
ing (nucleus, blue)362 Arch Dermatol Res (2010) 302:357–365
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ality of the cultured skin. Since the inXammatory response
of the ex vivo skin is comparable to recent studies on skin
infection and cutaneous cytokine induction, the feasibility
for interventional studies of wound infections using the Bo-
Drum® was conWrmed by the data of cytokine induction
after wound infection [15, 24]. An inXammatory cytokine
gene expression could be monitored in the Bo-Drum® for at
least 1 week, suggesting the viability of this model to ana-
lyse eVects of wound infections on transcriptional level.
In addition, histochemical analysis of the infected skin
was performed to visualize the structural settings of
infected ex vivo skin. H&E staining exhibited an intact epi-
dermis in non-infected skin. Consistent to Puissant [20],
there was a high bacterial load detected beneath the epider-
mis in infected samples, leading to an epidermolysis in
infected skin samples.
Thus, this model may be used for wound healing studies
focussing on the analysis of wound infection. Keratinocytes
undergo several kinds of behavioral changes, including pro-
liferation, migration, and diVerentiation [18], during reepi-
thelialization. However, further studies are clearly needed
to demonstrate whether this model is convenient for wound
healing studies.
In conclusion, the model described provides two com-
partments that could be treated or analyzed separately for
more than 4 weeks [28]. Wound infection studies can be
performed for more than 7 days on mRNA level. The
chamber presents a convenient, easy-to-use, and robust
model in which ex vivo full-thickness organ culture experi-
ments may be performed. In addition, this model might also
provide the opportunity to reduce or Wnally substitute in
vivo animal trials for wound infection and regeneration
studies. Moreover, this model provides potential for analy-
sis of potential new therapeutical strategies, topically
applied agents as well as gene therapy applications without
any systemic inXuences. Therefore, continuative studies
have to be accomplished to investigate its feasibility for
other studies of skin physiology and wound treatment,
wound healing and wound regeneration.
Materials and methods
Bo-Drum®
BO-Drum® is constructed out of two disk-shaped, stainless
steel plates (base plate and cover plate). The base plate has
a diameter of 3 cm with a central inner opening of 1 cm and
tri-spoke formed gaps to prevent formation of air bubbles
during incubation in nutrient media (Fig. 6). The cover
plate has a diameter of 3 cm and a 4 mm inner central open-
ing that is recessed 3.5 mm inferior to the remainder of the
drum surface. The skin is triangulated into the base plate
and the cover plate is secured without rotation force ensur-
ing minimal trauma to the skin during preparation.
Tissue
Skin explants were obtained from adult healthy patients
(age range = 19–52 years) undergoing abdominoplasty sur-
gery. The study was approved by the local ethics commit-
tee, and all of the patients gave written informed consent.
Immediately postexcision, the skin was washed in antisep-
tic (Octenisept, Schuelke-Mayr, Norderstedt, Germany)
three times for 10 s.
Organ culture
Human skin tissue was washed several times in phosphate
buVered saline (PBS) and subcutaneous fat was excised.
Next, the tissue was sliced into triangular pieces of
3 £ 3 cm. These pieces were transferred to the base of a
stainless steel chamber, placing the epithelial side upward.
The upper part of the chamber was bolt down until the tis-
sue was Wxed, and during Wxation, the skin explants were
stretched to prevent contraction. Samples were cultured at
the air–liquid interphase using a six-well plate Wlled with
5.5 ml of culture medium; DMEM (Gibco, 21969-035,
Paisley, England), containing 10% FBS (Hyclone, Logan,
Utah), 1% penicillin/streptomycin, and amphotericin B
(25 g/mL, PAA, Pasching, Austria) for 3 days. On day 3,
culture medium was changed to DMEM (Gibco, 21969-
035, Paisley, England), containing 10% FBS (Hyclone,
Logan, Utah) and cultured for another 3 days at 37°C in a
humidiWed atmosphere containing 5% CO2.
Bacteria
For bacterial inoculation, S. aureus and P. aeruginosa were
used. Bacteria were inoculated into Luria–Bertani broth
(International Diagnostics Group, Bury, Lancashire, UK)
and incubated overnight at 37°C. The cultures were centri-
fuged, and the bacterial pellets were diluted to a concentra-
tion of 1 £ 108 CFU/ml by use of the equation CFU/
ml = OD600 nm £ 2.5 £ 108. Each chamber was inocu-
lated with 20 l of bacterial suspension or Dulbecco’s
phosphate-buVered saline (PAA Laboratories, Linz, Aus-
tria) as carrier control.
Epidermal wounding and infection
For epidermal wounding, the epidermis was scratched
using a 3 mm punching knife. The punch knife was inserted
vertically into the Bo-Drum® and the skin was scratched
with a minimum force. For wound infection, skin was
inoculated with 105 CFU of P. aeruginosa (ATCC 27853)Arch Dermatol Res (2010) 302:357–365 363
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or S. aureus (ATCC 25923) by instilling the bacterial solu-
tion broadly into the inner opening.
Assessment of wound infection
For assessment of wound infection, tissue biopsies were
harvested from the wound and homogenized in PBS
(PT3100 Polytron, Kinematica, Littau-Luzern, Switzer-
land). Serially diluted aliquots of wound Xuid and homoge-
nate were analyzed on Luria–Bertani agar (International
Diagnostics Group, Bury, Lancashire, UK) and Pseudomo-
nas isolation agar (Becton Dickinson, Heidelberg, Ger-
many) for counts of S. aureus and P. aeruginosa. After
incubation for 18 h at 37°C, CFU were counted, and CFU/g
tissue was calculated as described previously [11].
Immunohistochemistry
Biopsy specimens were taken, Wxed in 4% neutral buVered
formalin, embedded in paraYn, and Wnally 4-m sections
were prepared. For histological assessment, a standard H&E
staining of these sections was performed. After heat Wxation,
deparaYnization, antigen unmasking, and blocking, slides
were incubated with the primary antibody [anti-S. aureus
antibody (Acris, Herford, Germany) at a dilution of 1:1,000].
The slides were incubated overnight at 4°C, rinsed with PBS
several times, and incubated with a corresponding biotinyla-
ted secondary antibody for 30 min at room temperature (RT).
After the washing procedure, sections were incubated in
streptavidin Alexa Fluor488 conjugate for 30 min at RT.
The slides were rinsed again and DAPI counterstaining
was performed. Finally, the slides were covered with Xuo-
rescent mounting medium (Dako, Hamburg, Germany).
Pictures were taken using an Axioskop 2 plus microscope
(Zeiss, Jena, Germany) connected to an AxioCam HRC
camera (Zeiss, Jena, Germany) at 50- to 400-fold magniW-
cation.
RNA isolation
Skin tissue has been taken and weighed in order not to
exceed 30 mg. Tissue was stored in liquid nitrogen until
further processing. Isolation of total RNA was done
using the RNeasy Mini Kit (Qiagen, Hilden, Germany),
following the manufacturer’s instructions for isolation of
total RNA from heart, muscle and skin including DNA-
digestion (RNase-free DNase Set, Qiagen, Hilden, Germany).
RNA was eluted in a Wnal volume of 30 l RNase-free
H2O. The concentration of RNA was determined using
the Eppendorf Biophotometer (Eppendorf, Hamburg,
Germany).
Reverse transcription
For reverse transcription, 1 g of total RNA was tran-
scribed into cDNA using the SuperScript™ II First Strand
Synthesis System for RT-PCR (Invitrogen, Karlsruhe, Ger-
many), following the manufacturer’s instructions for Wrst-
strand synthesis using random hexamer primers. cDNA was
stored at ¡20°C.
Fig. 6 Skin culture model. 
Upper panel depicts structure 
and alignment of the Bo-Drum®. 
The Bo-Drum® has a 4 mm inner 
central opening that is recessed 
3.5 mm inferior to the remainder 
of the drum surface (lid). The 
skin is triangulated into the base 
plate and the lid is secured with-
out rotation force ensuring mini-
mal trauma to the skin during 
preparation. The skin is Wxated 
under tension. Lower panel 
shows an assembled Bo-Drum®, 
which is further cultured in an 
air–liquid interface in a six-well 
plate using standard DMEM 
medium364 Arch Dermatol Res (2010) 302:357–365
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Real-time PCR
Relative quantiWcation of mRNA was performed in a two-
step real-time RT-PCR procedure using the Xuorescent dye
SYBR Green I (Light Cycler FastStart DNA Master SYBR
Green I, Roche, Mannheim, Germany) and a Light Cycler
1.0 (Roche, Mannheim, Germany). The Wrst step consisted
of an RT reaction as described above, the second step of
PCR ampliWcation with speciWc primers listed in Table 1.
These primer pairs were validated to generate a single PCR
product. The PCR reactions were performed with 2 l of
cDNA, 0.5 M of sense and antisense primers, 3 mM
MgCl2 and 2 l of FastStart SYBR Green reaction mix in a
total volume of 20 l. The cycling conditions were as fol-
lows: 95°C for 10 min at a ramp speed of 20°C/s, 40 cycles
(if not diVerently described) consisting of 94°C for 15 s at a
ramp speed of 20°C/s, A primer speciWc annealing temper-
ature (Table 1) for 10 s at a ramp speed of 20°C/s, 72°C for
10 s at a ramp speed of 20°C/s, followed by a melting point
analysis: 95°C for 0 s at a ramp speed of 20°C/s, 65°C for
15 s at a ramp speed of 20°C/s, 95°C for 0 s at a ramp speed
of 0.1°C/s, and Wnally a cooling phase: 40°C for 30 s at a
ramp speed of 20°C/s. mRNA concentrations were cor-
rected for 18S rRNA in each sample and were normalized
to an untreated control (x-fold expression). Primer
sequences for above-mentioned genes are as follows: 18S
sense 5-gaaactgcgaatggctcattaaa-3; 18S antisense 5-caca
gttatccaagtaggagagg-3 [annealing temperature (AT)
60°C]; IFN- sense 5-acccacagcctggataacag-3; IFN-
antisense 5-ctctcctcctgcatcacaca-3 (AT 60°C); IFN-
sense 5-actgcctcaaggacaggatg-3; IFN- antisense 5-agcc
aggaggttctcaacaa -3 (AT 60°C); IL-1 sense 5-aatgacgccc
tcaatcaaag-3 (AT 60°C); IL-1 antisense 5-tgggtatctcaggc
atctcc-3 (AT 60°C); IL-6 sense 5-caatgaggagacttgcctgg-3
(AT 63°C); IL-6 antisense 5-gcacagctctggcttgttcc-3 (AT
63°C); IL-8 sense 5-tctgcagctctgtgtgaagg-3 (AT 63°C);
IL-8 antisense 5-aatttctgtgttggcgcagt-3 (AT 63°C); TNF-
sense 5-aacctcctctctgccatcaa-3 (AT 62°C); TNF- anti-
sense 5-ggaagacccctcccagatag-3 (AT 62°C).
Statistical analysis
All assays were performed in triplicate. Data were analyzed
using analysis of variance and independent samples t test
(SPSS, Chicago, IL). A P value of less than 0.05 was
considered signiWcant compared to an untreated sample
(control sample).
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